Genomtec Investor Relations Material
Latest events
Investor Update
Genomtec
Q1 2025
29 May, 2025
Q4 2024
29 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Genomtec S.A
Access all reports
Genomtec S.A. is a biotechnology company specializing in molecular diagnostics. The company develops and commercializes portable and laboratory-based diagnostic solutions using isothermal nucleic acid amplification technology. Its products are designed for rapid and precise detection of infectious diseases, genetic disorders, and other medical conditions. The company is headquartered in Wrocław, Poland, and its shares are listed on the WSE.
Key slides for Genomtec S.A
Investor Update
Genomtec S.A
Investor Update
Genomtec S.A
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
GMT
Country
🇵🇱 Poland